Gianluca  Pettiti net worth and biography

Gianluca Pettiti Biography and Net Worth

Gianluca became Executive Vice President in January 2022, with responsibility for our Specialty Diagnostics, Life Sciences and Laboratory Products, and Genetic Sciences businesses, as well as our Chief Scientific Office and Quality/Regulatory function. Previously, he was Senior Vice President and President, Specialty Diagnostics, and in January 2021, he assumed additional responsibility for our clinical next-generation sequencing business. Gianluca joined the company through the acquisition of Life Technologies in 2014, where he was serving as President, Greater China. From 2015 through 2017, he led Thermo Fisher’s business in China, and became President, Biosciences, in 2018.

Gianluca began his career with General Electric and joined Life Technologies in 2006, serving in finance leadership roles in Europe before becoming Vice President and General Manager of the Latin America business in 2010 and assuming leadership of Greater China in 2013.

Gianluca earned a Master of Science degree in engineering from Politecnico di Torino in Italy. He served as a member of the Global Future Council on Health and Healthcare of the World Economic Forum from 2016 to 2018.

What is Gianluca Pettiti's net worth?

The estimated net worth of Gianluca Pettiti is at least $8.83 million as of October 25th, 2024. Mr. Pettiti owns 16,663 shares of Thermo Fisher Scientific stock worth more than $8,830,557 as of December 3rd. This net worth evaluation does not reflect any other investments that Mr. Pettiti may own. Additionally, Mr. Pettiti receives a salary of $1,660,000.00 as EVP at Thermo Fisher Scientific. Learn More about Gianluca Pettiti's net worth.

How old is Gianluca Pettiti?

Mr. Pettiti is currently 45 years old. There are 6 older executives and no younger executives at Thermo Fisher Scientific. The oldest executive at Thermo Fisher Scientific is Mr. Michael A. Boxer Esq., Senior VP & General Counsel, who is 62 years old. Learn More on Gianluca Pettiti's age.

What is Gianluca Pettiti's salary?

As the EVP of Thermo Fisher Scientific Inc., Mr. Pettiti earns $1,660,000.00 per year. There are 4 executives that earn more than Mr. Pettiti. The highest earning executive at Thermo Fisher Scientific is Mr. Marc N. Casper, Chairman, President & CEO, who commands a salary of $5,080,000.00 per year. Learn More on Gianluca Pettiti's salary.

How do I contact Gianluca Pettiti?

The corporate mailing address for Mr. Pettiti and other Thermo Fisher Scientific executives is 168 Third Avenue, Waltham MA, 02451. Thermo Fisher Scientific can also be reached via phone at (781) 622-1000 and via email at [email protected]. Learn More on Gianluca Pettiti's contact information.

Has Gianluca Pettiti been buying or selling shares of Thermo Fisher Scientific?

During the last quarter, Gianluca Pettiti has sold $168,048.00 in shares of Thermo Fisher Scientific stock. Most recently, Gianluca Pettiti sold 300 shares of the business's stock in a transaction on Friday, October 25th. The shares were sold at an average price of $560.16, for a transaction totalling $168,048.00. Following the completion of the sale, the executive vice president now directly owns 16,663 shares of the company's stock, valued at $9,333,946.08. Learn More on Gianluca Pettiti's trading history.

Who are Thermo Fisher Scientific's active insiders?

Thermo Fisher Scientific's insider roster includes Michael Boxer (SVP), Lisa Britt (Senior Vice President and Chief Human Resources Officer), Marc Casper (Chairman, President & CEO), Joseph Holmes (VP & CAO), Peter Hornstra (CAO), Syed Jafry (VP), Michel Lagarde (EVP), Jim Manzi (Director), Gianluca Pettiti (EVP), Debora Spar (Director), Mark Stevenson (COO), and Stephen Williamson (CFO). Learn More on Thermo Fisher Scientific's active insiders.

Are insiders buying or selling shares of Thermo Fisher Scientific?

During the last twelve months, insiders at the medical research company sold shares 21 times. They sold a total of 132,511 shares worth more than $75,792,321.00. The most recent insider tranaction occured on November, 8th when CEO Marc N Casper sold 9,000 shares worth more than $4,975,740.00. Insiders at Thermo Fisher Scientific own 0.3% of the company. Learn More about insider trades at Thermo Fisher Scientific.

Information on this page was last updated on 11/8/2024.

Gianluca Pettiti Insider Trading History at Thermo Fisher Scientific

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/25/2024Sell300$560.16$168,048.0016,663View SEC Filing Icon  
7/26/2024Sell300$600.85$180,255.0017,887View SEC Filing Icon  
8/30/2023Sell3,000$557.77$1,673,310.0017,556View SEC Filing Icon  
12/13/2022Sell4,975$576.84$2,869,779.0016,450View SEC Filing Icon  
See Full Table

Gianluca Pettiti Buying and Selling Activity at Thermo Fisher Scientific

This chart shows Gianluca Pettiti's buying and selling at Thermo Fisher Scientific by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Thermo Fisher Scientific Company Overview

Thermo Fisher Scientific logo
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Read More

Today's Range

Now: $531.68
Low: $527.94
High: $535.98

50 Day Range

MA: $566.33
Low: $501.50
High: $619.45

2 Week Range

Now: $531.68
Low: $487.06
High: $627.88

Volume

959,730 shs

Average Volume

1,513,881 shs

Market Capitalization

$203.37 billion

P/E Ratio

33.33

Dividend Yield

0.29%

Beta

0.77